Women's History Month: Pharmacy Chains CVS Health, Walgreens To Start Dispensing Abortion Pill Mifepristone In Select States
Portfolio Pulse from Vandana Singh
CVS Health Corp (CVS) and Walgreens Boots Alliance Inc (WBA) announced plans to dispense the abortion pill mifepristone in select states, following FDA guidelines. The rollout will begin in states like New York, Pennsylvania, Massachusetts, California, and Illinois for Walgreens, and Massachusetts and Rhode Island for CVS. The expansion will continue in states where abortion is legal and pharmacy dispensation is allowed. The Supreme Court's upcoming decision on mifepristone could impact its availability. CVS stock is down 0.55%, while WBA shares are up 0.98%.
March 01, 2024 | 8:41 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CVS Health Corp plans to dispense mifepristone in select states, starting with Massachusetts and Rhode Island. The stock is currently down 0.55%.
The announcement by CVS to dispense mifepristone could have a neutral to slightly positive impact on its stock in the short term, as it may attract customers in states where the service is offered. However, the current stock dip suggests market uncertainty or unrelated factors influencing the price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
NEUTRAL IMPACT
Walgreens Boots Alliance Inc to begin dispensing mifepristone in NY, PA, MA, CA, and IL. Shares are up 0.98%.
Walgreens' decision to dispense mifepristone in select states could potentially have a neutral to slightly positive impact on its stock due to increased customer traffic in those areas. The current increase in share price indicates a positive market reaction, though it's unclear if this is directly related to the announcement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90